Two months of doxorubicin-cyclophosphamide with and without reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positivenode breast cancer patients with tamoxifen-nonresponsive tumors: Results from the National Surgical Adjuvant Breast and Bowel Project B-15 - Fisher,B..; Brown,A..M..; Dimitrov,N..V..; Poisson,R..; Redmond,C.. (J Clin Oncol, 1990)